Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.

about

Relamorelin for the treatment of gastrointestinal motility disorders.Glass half empty? Lessons learned about gastroparesis.Diabetic gastroparesis: current challenges and future prospects Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism

P2860

Q39150802-27AEA64D-684B-4D0E-87BD-5FA250C5BBC5 Q54959864-8BC42EBC-A79C-44E3-8822-00C16F6D8413 Q57491893-E4BC2C8D-C131-4559-8079-4A46F3A52CF8 Q58699538-3BEC9EFF-AEBA-4A3E-AAA4-4AF004A95158

P2860

Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.

Item

http://www.wikidata.org/entity/Q47816254

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@en

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@nl

type

Item

label

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@en

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@nl

prefLabel

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@en

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@nl

P1476

Efficacy and Safety of Relamor ...... zed, Placebo-Controlled Study.

@en

P2093

Fred T Fiedorek

http://www.w3.org/2001/XMLSchema#string

Jan Tack

http://www.w3.org/2001/XMLSchema#string

Keith Gottesdiener

http://www.w3.org/2001/XMLSchema#string

Richard W McCallum

http://www.w3.org/2001/XMLSchema#string

Sharon C Spence

http://www.w3.org/2001/XMLSchema#string

P2860

The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

Clinical guideline: management of gastroparesis

Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.

The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride)

Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.

Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population.

Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.

Gastric motility, gastroparesis, and gastric stimulation.

P304

1240-1250.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2017.07.035

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

Michael Camilleri

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28760384

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5670003

http://www.w3.org/2001/XMLSchema#string

Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.

about

P2860

P2860

Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932